Literature DB >> 8200018

Abnormal platelet mitochondrial function in patients affected by migraine with and without aura.

S Sangiorgi1, M Mochi, R Riva, P Cortelli, L Monari, G Pierangeli, P Montagna.   

Abstract

To investigate energy metabolism in migraine, we determined platelet mitochondrial enzyme activities in 40 patients with migraine with aura and in 40 patients with migraine without aura during attack-free intervals and in 24 healthy control subjects. NADH-dehydrogenase, citrate synthase and cytochrome-c-oxidase activities in both patient groups were significantly lower than in controls (p < 0.01), while NADH-cytochrome-c-reductase activity was reduced only in migraine with aura (p < 0.01). No alteration in succinate-dehydrogenase was observed. Monoamine-oxidase activity differed between sexes (p < 0.05) but within each sex group no difference was observed between patients and controls. We hypothesize that the defect in mitochondrial enzymes observed indicates a systemic impairment of mitochondrial function in migraine patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8200018     DOI: 10.1046/j.1468-2982.1994.1401021.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  20 in total

1.  Is there an association between NC_012920.1: m.8277T> C mitochondrial variation the mt-NC7 locus, and migraine with aura?

Authors:  S Güler; H Gürkan; S Demir
Journal:  Hippokratia       Date:  2020 Apr-Jun       Impact factor: 0.471

2.  Functional mitochondrial analysis in acute brain sections from adult rats reveals mitochondrial dysfunction in a rat model of migraine.

Authors:  Nathan T Fried; Cynthia Moffat; Erin L Seifert; Michael L Oshinsky
Journal:  Am J Physiol Cell Physiol       Date:  2014-09-24       Impact factor: 4.249

Review 3.  A possible role for mitochondrial dysfunction in migraine.

Authors:  S Stuart; L R Griffiths
Journal:  Mol Genet Genomics       Date:  2012-10-07       Impact factor: 3.291

4.  Riboflavin and migraine: the bridge over troubled mitochondria.

Authors:  Bruno Colombo; Lorenzo Saraceno; Giancarlo Comi
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

Review 5.  Kynurenines and headache.

Authors:  Arpád Párdutz; Annamária Fejes; Zsuzsanna Bohár; Lilla Tar; József Toldi; László Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2011-06-04       Impact factor: 3.575

Review 6.  Brain Energy Deficit as a Source of Oxidative Stress in Migraine: A Molecular Basis for Migraine Susceptibility.

Authors:  Jonathan M Borkum
Journal:  Neurochem Res       Date:  2021-04-30       Impact factor: 3.996

7.  Prevalence and risk of migraine headaches in adult fragile X premutation carriers.

Authors:  J Au; R S Akins; L Berkowitz-Sutherland; H-T Tang; Y Chen; A Boyd; F Tassone; D V Nguyen; R Hagerman
Journal:  Clin Genet       Date:  2013-02-21       Impact factor: 4.438

Review 8.  The Evidence for the Role of Nutraceuticals in the Management of Pediatric Migraine: a Review.

Authors:  Serena L Orr
Journal:  Curr Pain Headache Rep       Date:  2018-04-04

Review 9.  Blood-based bioenergetics: An emerging translational and clinical tool.

Authors:  Andrea Braganza; Gowtham K Annarapu; Sruti Shiva
Journal:  Mol Aspects Med       Date:  2019-12-18

10.  Treatment of cyclic vomiting syndrome with co-enzyme Q10 and amitriptyline, a retrospective study.

Authors:  Richard G Boles; Mary R Lovett-Barr; Amy Preston; B Uk Li; Kathleen Adams
Journal:  BMC Neurol       Date:  2010-01-28       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.